Shulan Han

Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.

Vorinostat nanoformulation triggers cell cycle blockade and apoptosis for colorectal cancer therapy.

Journal: International journal of pharmaceutics

Published: April 24, 2026

Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nanoadjuvant Enhances the Immunity and Cross-Protection of an NM2e-Based Universal Influenza Vaccine.

Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nanoadjuvant Enhances the Immunity and Cross-Protection of an NM2e-Based Universal Influenza Vaccine.

Journal: ACS nano

Published: May 09, 2024

Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.

Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: March 14, 2024

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.

Journal: Science advances

Published: July 19, 2023

Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.

Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: February 14, 2023

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles.

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles.

Journal: Journal of functional biomaterials

Published: January 07, 2023

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.

Journal: International journal of pharmaceutics

Published: November 23, 2022

Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.

Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.

Journal: Fundamental research

Published: November 20, 2022

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 01, 2022

Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.

Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.

Journal: Journal of nanobiotechnology

Published: August 22, 2021

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

Journal: International journal of pharmaceutics

Published: March 10, 2021

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.

Journal: Acta pharmaceutica Sinica. B

Published: March 07, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026